Altered Metabolic Profiles of the Plasma of Patients with Amyotrophic Lateral Sclerosis

Currently, there is no objective biomarker to indicate disease progression and monitor therapeutic effects for amyotrophic lateral sclerosis (ALS). This study aimed to identify plasma biomarkers for ALS using a targeted metabolomics approach. Plasma levels of 185 metabolites in 36 ALS patients and 3...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Kuo-Hsuan, Lin, Chia-Ni, Chen, Chiung-Mei, Lyu, Rong-Kuo, Chu, Chun-Che, Liao, Ming-Feng, Huang, Chin-Chang, Chang, Hong-Shiu, Ro, Long-Sun, Kuo, Hung-Chou
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8699018/
https://www.ncbi.nlm.nih.gov/pubmed/34944760
http://dx.doi.org/10.3390/biomedicines9121944

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8699018/
https://www.ncbi.nlm.nih.gov/pubmed/34944760
http://dx.doi.org/10.3390/biomedicines9121944

Ejemplares similares